Fowler CJ et al. |
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. |
1999 |
Arch. Biochem. Biophys. |
pmid:9989926
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Di Marzo V and Deutsch DG |
Biochemistry of the endogenous ligands of cannabinoid receptors. |
1998 |
Neurobiol. Dis. |
pmid:9974173
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Lu R et al. |
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. |
1999 |
Am. J. Physiol. |
pmid:9950961
|
Goparaju SK et al. |
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. |
1999 |
Biochem. Pharmacol. |
pmid:9933030
|
Wagner JA et al. |
Mesenteric vasodilation mediated by endothelial anandamide receptors. |
1999 |
Hypertension |
pmid:9931142
|
Basavarajappa BS and Hungund BL |
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. |
1999 |
J. Neurochem. |
pmid:9930723
|
Beltramo M and Piomelli D |
Anandamide transport inhibition by the vanilloid agonist olvanil. |
1999 |
Eur. J. Pharmacol. |
pmid:9920187
|
Sugiura T et al. |
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. |
1999 |
J. Biol. Chem. |
pmid:9915812
|
Lin S et al. |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. |
1998 |
J. Med. Chem. |
pmid:9876105
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Bonhaus DW et al. |
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9864268
|
Stahl SM |
Getting stoned without inhaling: anandamide is the brain's natural marijuana. |
1998 |
J Clin Psychiatry |
pmid:9862600
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Pate DW et al. |
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. |
1998 |
Life Sci. |
pmid:9851310
|
Castellano C et al. |
The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors. |
1997 |
Behav Pharmacol |
pmid:9832956
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Maccarrone M et al. |
Anandamide hydrolysis by human cells in culture and brain. |
1998 |
J. Biol. Chem. |
pmid:9822713
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
Murillo-RodrÃguez E et al. |
Anandamide modulates sleep and memory in rats. |
1998 |
Brain Res. |
pmid:9813364
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
White R and Hiley CR |
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. |
1998 |
Br. J. Pharmacol. |
pmid:9806337
|
Stein EA et al. |
Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. |
1998 |
Neuropsychopharmacology |
pmid:9803424
|
Di Marzo V et al. |
Interactions between synthetic vanilloids and the endogenous cannabinoid system. |
1998 |
FEBS Lett. |
pmid:9801167
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Pestonjamasp VK and Burstein SH |
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. |
1998 |
Biochim. Biophys. Acta |
pmid:9795237
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Jaggar SI et al. |
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. |
1998 |
Neurosci. Lett. |
pmid:9774165
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Schneider U et al. |
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? |
1998 |
Pharmacopsychiatry |
pmid:9754842
|
McGregor IS et al. |
A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. |
1998 |
Brain Res. |
pmid:9748483
|
Molina-Holgado F et al. |
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. |
1998 |
FEBS Lett. |
pmid:9738948
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Welch SP et al. |
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732392
|
Fulton D and Quilley J |
Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732371
|
Berdyshev E et al. |
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. |
1998 |
Life Sci. |
pmid:9718090
|
Childers SR and Breivogel CS |
Cannabis and endogenous cannabinoid systems. |
1998 Jun-Jul |
Drug Alcohol Depend |
pmid:9716939
|
Varga K et al. |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. |
1998 |
FASEB J. |
pmid:9707176
|
Bisogno T et al. |
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703957
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Qin C et al. |
Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. |
1998 |
Anal. Biochem. |
pmid:9683506
|
van Zadelhoff G et al. |
With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9675081
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
De Petrocellis L et al. |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9653194
|
Mallet PE and Beninger RJ |
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. |
1998 |
Life Sci. |
pmid:9651110
|
Stefano GB et al. |
Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641470
|
Stefano GB et al. |
Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641464
|
Kondo S et al. |
Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. |
1998 |
Arch. Biochem. Biophys. |
pmid:9637740
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Stefano GB et al. |
Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. |
1998 |
Brain Res. |
pmid:9630717
|
Di Marzo V |
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
1998 |
Biochim. Biophys. Acta |
pmid:9630590
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Prevot V et al. |
Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. |
1998 |
Brain Res. |
pmid:9593913
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Derocq JM et al. |
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. |
1998 |
FEBS Lett. |
pmid:9563506
|
Qureshi J et al. |
Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol. |
1998 |
Mol. Cell. Biochem. |
pmid:9562238
|
Soderstrom K et al. |
Discovery of novel cannabinoid receptor ligands from diverse marine organisms. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561107
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Salzet M et al. |
Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph proopiomelanocortin processing. |
1997 |
J. Immunol. |
pmid:9548480
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Pratt PF et al. |
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. |
1998 |
Am. J. Physiol. |
pmid:9458889
|
Hillard CJ and Campbell WB |
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. |
1997 |
J. Lipid Res. |
pmid:9458263
|
Hampson AJ et al. |
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. |
1998 |
J. Neurochem. |
pmid:9453561
|
Pate DW et al. |
Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. |
1997 |
Pharm. Res. |
pmid:9453062
|
Thomas EA et al. |
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. |
1997 |
J. Neurosci. Res. |
pmid:9452020
|
Chakrabarti A et al. |
Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. |
1998 |
Brain Res. Bull. |
pmid:9434204
|
Jarrahian A and Hillard CJ |
Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. |
1997 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:9431821
|
Zygmunt PM et al. |
Studies on the effects of anandamide in rat hepatic artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422814
|
White R and Hiley CR |
A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422801
|
Wiley JL et al. |
Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9408225
|
Compton DR and Martin BR |
The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9399986
|
Wagner JA et al. |
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. |
1997 |
Nature |
pmid:9394002
|
Calignano A et al. |
Potentiation of anandamide hypotension by the transport inhibitor, AM404. |
1997 |
Eur. J. Pharmacol. |
pmid:9389389
|
Burkey TH et al. |
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. |
1997 |
Eur. J. Pharmacol. |
pmid:9384246
|
Randall MD and Kendall DA |
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. |
1997 |
Eur. J. Pharmacol. |
pmid:9369375
|
Sasaki T and Chang MC |
N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes. |
1997 |
Life Sci. |
pmid:9365227
|
van der Stelt M et al. |
The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties. |
1997 |
FEBS Lett. |
pmid:9357990
|
Seltzman HH et al. |
Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. |
1997 |
J. Med. Chem. |
pmid:9357529
|
Ryan WJ et al. |
Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. |
1997 |
J. Med. Chem. |
pmid:9357528
|
Stark S et al. |
Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells. |
1997 |
Cell. Mol. Neurobiol. |
pmid:9353590
|